# How Cannabis Transforms Animal Medicine > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoid-therapeutics-veterinary-medicine/ > **Published:** 2026-03-03T11:44:11-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T14:04:25-04:00 > **Clinical Summary:** Explore cannabinoid therapeutics veterinary medicine for pain and seizure control, highlighting parallels with human pharmacology and emerging research. --- ✦ New CED Clinical Relevance#62 Notable Clinical InterestEmerging findings or policy developments worth monitoring closely. PainNeurologyResearchCBD Why This MattersCannabinoid therapeutics in veterinary medicine provide clinically relevant parallels for human pharmacology, particularly regarding pain management and seizure control where conventional agents show limited efficacy or significant adverse effects. The growing body of veterinary evidence establishes dosing parameters and safety profiles that can inform future controlled trials in human patients with treatment-resistant conditions. Understanding cannabinoid mechanisms in animal models accelerates translation to clinical practice by identifying specific indications where [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) modulation offers superior therapeutic windows compared to existing pharmacotherapies. Dr. Caplan’s Take“We’re seeing in veterinary medicine what I’ve observed in my own clinical practice: cannabinoids have genuine therapeutic utility for specific conditions like [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) and seizure disorders, but this doesn’t make cannabis a panacea, and we need the same rigorous dosing protocols and outcome tracking in animals that responsible practitioners demand for their human patients.” Clinical Perspective While [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) in veterinary medicine shows promising signals for pain, epilepsy, and inflammatory conditions, the evidence base remains preliminary and heavily weighted toward small animal studies, limiting direct extrapolation to clinical human populations. The translation from animal models to human therapeutics is complicated by differences in metabolism, dosing kinetics, regulatory status across jurisdictions, and the heterogeneity of cannabis preparations currently available, making it difficult to establish standardized treatment protocols. Additionally, most veterinary cannabinoid studies lack rigorous blinding, adequate controls, and long-term safety monitoring, raising questions about effect magnitude beyond placebo and the risk of adverse events in chronic use. Healthcare providers should recognize that cannabis preparations marketed for human patients often lack the same regulatory scrutiny applied to veterinary pharmaceuticals, and extrapolating animal evidence to clinical human practice remains speculative. Until well-designed human trials establish efficacy and safety profiles with clearly defined dosing reg 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+How+Cannabis+Transforms+Animal+Medicine+%40drcaplan&url=https%3A%2F%2Fsechat.com.br%2Fen%2Fnoticia%2Fhow-cannabis-transforms-animal-medicine) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fsechat.com.br%2Fen%2Fnoticia%2Fhow-cannabis-transforms-animal-medicine) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+How+Cannabis+Transforms+Animal+Medicine+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fsechat.com.br%2Fen%2Fnoticia%2Fhow-cannabis-transforms-animal-medicine) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://sechat.com.br/en/noticia/how-cannabis-transforms-animal-medicine](https://sechat.com.br/en/noticia/how-cannabis-transforms-animal-medicine) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Research Digest[Daily Digest 2026-03-07](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Flourish + Live Well's CBD Science Series CBD and Seizures in Dogs: What Science … – Instagram](https://cedclinic.com/a-new-hope-for-seizures-exploring-cbd-s-potential-for-dogs-with-epilepsy/) Explore scientific insights into CBD use for seizure management in dogs, highlighting veterinary applications and clinical observations. [Learn about CBD for seizures](https://cedclinic.com/a-new-hope-for-seizures-exploring-cbd-s-potential-for-dogs-with-epilepsy/) [Exploring Cannabinoids and Their Role in Patient Care – Cannabis News | NUG Magazine](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) An overview of cannabinoids' therapeutic roles across [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), including veterinary and human medicine perspectives. [Discover cannabinoid roles](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) The Science Behind Cannabis and Its [Therapeutic Benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) – NUG Magazine Detailed review of cannabis [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) supported by scientific research, relevant to both animal and human health. Read about cannabis benefits ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).